Early central vs. peripheral immunological and neurobiological effects of fingolimod—a longitudinal study

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

Ludwig Kappos, Ernst‐Wilhelm Radue, Paul O’Connor et al. · New England Journal of Medicine · 2010 · 2.6K citations · Full text

Life Sciences, Neurology, Pharmacotherapy +14

Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis

Jeffrey A. Cohen, Frederik Barkhof, Hans‐Peter Hartung et al. · New England Journal of Medicine · 2010 · 2.2K citations · Full text

Life Sciences, Immunology, Neurology +15

Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis

Giulio Disanto, Christian Barro, Pascal Benkert et al. · Annals of Neurology · 2017 · 1.2K citations · Full text

Life Sciences, Neurology, Neuroscience +16

Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa

Jens Kühle, Christian Barro, Ulf Andréasson et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 2016 · 739 citations

Life Sciences, Neurology, Neuroscience +13

The Simoa HD-1 Analyzer: A Novel Fully Automated Digital Immunoassay Analyzer with Single-Molecule Sensitivity and Multiplexing

David H. Wilson, David M. Rissin, Cheuk W. Kan et al. · SLAS TECHNOLOGY · 2015 · 474 citations · Full text

Life Sciences, Bioengineering, Biotechnology +14